David Granot - Net Worth and Insider Trading
David Granot Net Worth
The estimated net worth of David Granot is at least $361,724 dollars as of 2024-09-20. David Granot is the Director of Ormat Technologies Inc and owns about 4,832 shares of Ormat Technologies Inc (ORA) stock worth over $361,724. Details can be seen in David Granot's Latest Holdings Summary section.
Disclaimer: The insider information is derived from SEC filings. The estimated net worth is based on the final shares held after open market or private purchases and sales of common stock with a transaction code of "P" or "S" on Form 4, assuming that David Granot has not made any transactions after 2024-05-30 and currently still holds the listed stock(s). Please note that this estimate may not reflect the actual net worth.
Transaction Summary of David Granot
David Granot Insider Ownership Reports
Based on ownership reports from SEC filings, as the reporting owner, David Granot owns 2 companies in total, including Protalix BioTherapeutics Inc (PLX) , and Ormat Technologies Inc (ORA) .
Click here to see the complete history of David Granot’s form 4 insider trades.
Insider Ownership Summary of David Granot
| Ticker | Comapny | Transaction Date | Type of Owner |
|---|---|---|---|
| PLX | Protalix BioTherapeutics Inc | 2020-01-20 | director |
| ORA | Ormat Technologies Inc | 2024-05-30 | director |
David Granot Latest Holdings Summary
David Granot currently owns a total of 1 stock. David Granot owns 4,832 shares of Ormat Technologies Inc (ORA) as of May 30, 2024, with a value of $361,724.
Latest Holdings of David Granot
| Ticker | Comapny | Latest Transaction Date | Shares Owned | Current Price ($) | Current Value ($) |
|---|---|---|---|---|---|
| ORA | Ormat Technologies Inc | 2024-05-30 | 4,832 | 74.86 | 361,724 |
Holding Weightings of David Granot
David Granot Form 4 Trading Tracker
According to the SEC Form 4 filings, David Granot has made a total of 8 transactions in Ormat Technologies Inc (ORA) over the past 5 years, including 0 buys and 8 sells. The most-recent trade in Ormat Technologies Inc is the sale of 686 shares on May 30, 2024, which brought David Granot around $50,394.
Insider Trading History of David Granot
- 1
David Granot Trading Performance
David Granot Ownership Network
David Granot Owned Company Details
What does Protalix BioTherapeutics Inc do?
Who are the key executives at Protalix BioTherapeutics Inc?
David Granot is the director of Protalix BioTherapeutics Inc. Other key executives at Protalix BioTherapeutics Inc include director & President and CEO Dror Bashan , 10 percent owner Dexcel Pharma Technologies Ltd. , and 10 percent owner Dan Oren .
Protalix BioTherapeutics Inc (PLX) Insider Trades Summary
Over the past 18 months, David Granot made no insider transaction in Protalix BioTherapeutics Inc (PLX). Other recent insider transactions involving Protalix BioTherapeutics Inc (PLX) include a net purchase of 64,516 shares made by Dror Bashan ,
In summary, during the past 3 months, insiders sold 0 shares of Protalix BioTherapeutics Inc (PLX) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Protalix BioTherapeutics Inc (PLX) were sold and 64,516 shares were bought by its insiders, resulting in a net purchase of 64,516 shares.
Protalix BioTherapeutics Inc (PLX)'s detailed insider trading history can be found in Insider Trading Tracker table.
Protalix BioTherapeutics Inc Insider Transactions
David Granot Mailing Address
Above is the net worth, insider trading, and ownership report for David Granot. You might contact David Granot via mailing address: 6225 Neil Road, Reno Nv 89511.
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
